Tevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides

Go back to Tevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides

Microsoft (MSFT) PT Raised to $613 at Citi

July 22, 2025 6:31 AM EDT

Citi analyst Tyler Radke raised the price target on Microsoft (NASDAQ: MSFT) to $613.00 (from $605.00) while maintaining a Buy rating.

The analyst comments "We reiterate our bullish view into MSFTs F4Q results, anticipating another strong quarter of positive revisions and... More